These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5810012)

  • 1. [Persistence and renal excretions of low molecular weight dextran in newborns and infants].
    Emmrich P; Jüngst BK; Appel W
    Z Kinderheilkd; 1969; 106(4):298-307. PubMed ID: 5810012
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants.
    Emmrich P; Baumann W; Stechele U
    Eur J Pediatr; 1977 Jul; 125(3):181-90. PubMed ID: 885145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal molecular weight for the blood substitute polyglucin.
    Rozenberg GY; From AA; Polushina TV; Chernysheva EA; Lavrova RI
    Fed Proc Transl Suppl; 1966; 25(5):805-8. PubMed ID: 5223564
    [No Abstract]   [Full Text] [Related]  

  • 4. The renal handling of dextran 40 by surgical patients.
    Heale WF; Niall JF; Doyle JC
    Aust N Z J Surg; 1968 Nov; 38(2):168-72. PubMed ID: 5247982
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravascular persistence and renal clearance of dextran of different molecular sizes in normal children.
    Arturson G; Granath K; Grotte G
    Arch Dis Child; 1966 Apr; 41(216):168-71. PubMed ID: 5909827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dextran and dextran-derivatives].
    Görlich B
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1969 Jun; 39(7):149-67. PubMed ID: 5395997
    [No Abstract]   [Full Text] [Related]  

  • 7. Isotopically labelled macromolecules in biological research: dextran labelled with radioactive iodine.
    Ricketts CR
    Nature; 1966 Jun; 210(5041):1113-5. PubMed ID: 5964169
    [No Abstract]   [Full Text] [Related]  

  • 8. Glomerular permeability to serum proteins and high molecular weight dextrans in glomerulonephritis.
    Petrie JJ; MacLean PR; Robson JS
    Clin Sci; 1968 Feb; 34(1):83-95. PubMed ID: 5640686
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the molecular spectrum of dextran 40,000 in the blood serum of patients after bilateral nephrectomy and in healthy subjects.
    Lutz W; Markiewicz K; Walasek L
    Mater Med Pol; 1974; 6(1):6-9. PubMed ID: 4444330
    [No Abstract]   [Full Text] [Related]  

  • 10. A rapid renal clearance methodology for dextran.
    Leypoldt JK; Frigon RP; DeVore KW; Henderson LW
    Kidney Int; 1987 Mar; 31(3):855-60. PubMed ID: 2437354
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low-molecular dextran in the treatment of cardiogenic shock].
    Dyduszyński A
    Pol Tyg Lek; 1969 Jul; 24(27):1059-61. PubMed ID: 5805885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the fate of injected dextran in the guinea pig].
    Ebert KH; Schenk G; Scholz R
    Z Klin Chem Klin Biochem; 1968 Sep; 6(5):435-41. PubMed ID: 5724319
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low molecular dextran in the treatment of shock not related to the primary loss of body fluids].
    Dyduszyński A
    Pol Tyg Lek; 1969 Jan; 24(4):121-4. PubMed ID: 4887633
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple method for determination of dextran in blood and urine.
    JACOBSSON L; HANSEN H
    Scand J Clin Lab Invest; 1952; 4(4):352-4. PubMed ID: 13048616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiogenic shock following myocardial infarct. Therapeutic results with isoprenaline and low-molecular dextran].
    Nager F; Lichtlen P; Rösli R; Steinbrunn W; Gutschmidt A; Reutter F; Blankart R; Reichmuth J; Burger H; Affolter H; Debrunner F; Ritz R; Uehlinger A; Meyer HA
    Dtsch Med Wochenschr; 1969 Aug; 94(33):1640-5. PubMed ID: 5795243
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of low molecular weight dextran in endotoxin shock.
    Yanchick VA
    Bull Parenter Drug Assoc; 1966; 20(6):173-82. PubMed ID: 5956954
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with low molecular weight dextran in acute myocardial infarction.
    Langsjoen PH
    J Miss State Med Assoc; 1969 Nov; 10(11):499-502. PubMed ID: 5352795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of indications for clinical use of dextran in the light of experiences of the Institute of Hematology].
    Rudowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1044-7. PubMed ID: 5805882
    [No Abstract]   [Full Text] [Related]  

  • 19. The microcirculatory effects of dextran.
    Stalker AL
    J Pathol Bacteriol; 1967 Jan; 93(1):191-201. PubMed ID: 6029757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary excretion of dextran preparations of various molecular weights, with special reference to the molecular weight distribution and excretion of Plasmodex].
    Simon S
    Acta Pharm Hung; 1967 Jul; 37(4):178-85. PubMed ID: 5601700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.